ArticleMolecular diversity2024

Multi-method computational evaluation of the inhibitors against leucine-rich repeat kinase 2 G2019S mutant for Parkinson's disease.

Ahmed Elhadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.